ÂÜÀòÂÒÂ×

Jason Whaley is a seasoned venture capital professional currently serving as a General Partner at Rhapsody Venture Partners since May 2016, focusing on investments in early-stage start-ups within applied science and engineering innovation. In addition to this role, Jason holds board positions at multiple companies such as CNERGREEN, Holiferm, Verdafresh, Sensatek Propulsion Technology, and Fluid Efficiency. Previously, Jason was the CEO of Manus Biosynthesis, where the company leveraged biotechnology to produce natural products, and served as Chief Operating Officer at FA, driving significant growth. Earlier experience includes a seven-year tenure at Monitor Group, where Jason worked in various roles that involved strategy consulting across multiple industries globally. Jason holds an MBA from MIT Sloan School of Management and a BA in Computer Science from Dartmouth College.